{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T07:00:29Z","timestamp":1763622029181,"version":"3.45.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study systematically compares the safety information presented on drug labels for antineoplastic and supportive care medications listed on the WHO Essential Medicines List (EML) across three major pharmaceutical markets: China, Japan, and the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The safety information of the same drugs approved in the three countries was compared and analyzed, involving the calculation of the proportion of each safety information and the percentage of boxed warnings (PBW) to all information on the label, we also comparative analysis of pediatric medication information studied from each country.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were substantial differences in each safety information of the labels in three countries. Except for the proportion of information on use in the elderly, the proportion of each type of safety information differed significantly between countries, and the content also varied widely. Concordance of the presence or the absence of a BW on the label between China, Japan, and the US was 36% on the total labels. Of the 19 drugs, Japan had the most pediatric drug information with 13 drugs, followed by the US with nine drugs and China with eight drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There were significant differences in the safety information on drug labels in China, Japan, and the US from the same manufacturer, which could pose a risk to patients. Regulatory agencies should better align their approaches to labeling to prevent confusion or misunderstanding across regions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1600207","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:19:59Z","timestamp":1763619599000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A comparison of the labeling of antineoplastic and supportive medicines in China, Japan, and the US based on the WHO essential medicines list"],"prefix":"10.3389","volume":"12","author":[{"given":"Chenyu","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengcheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11096-013-9755-2","article-title":"Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian regulatory agency versus FDA","volume":"35","author":"Borges","year":"2013","journal-title":"Int J Clin Pharm"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"7485","DOI":"10.1016\/j.vaccine.2020.09.067","article-title":"Elements of regulatory dissonance: examining FDA and EMA product labeling of new vaccines (2006\u20132018)","volume":"38","author":"Seo","year":"2020","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/cpt.1640","article-title":"International coherence of pediatric drug labeling for drug safety: comparison of approved labels in Korea and the United States","volume":"107","author":"Song","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/pds.3408","article-title":"Safety information in drug labeling: a comparison of the USA, the UK, and Japan","volume":"22","author":"Shimazawa","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/pds.4111","article-title":"Differences between the United States and Japan in labels of oncological drugs","volume":"26","author":"Jayaputra","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s43441-022-00431-y","article-title":"A comparison of safety information in drug labeling at the initial approval of new drugs approved both in Japan and the United States","volume":"56","author":"Hoshino","year":"2022","journal-title":"Ther Innov Regul Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/pds.5203","article-title":"A comparison of decision and timing of safety related labeling changes for new drugs approved both in Japan and the United States","volume":"30","author":"Hoshino","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.20892\/j.issn.2095-3941.2022.0231","article-title":"Current cancer burden in China: epidemiology, etiology, and prevention","volume":"19","author":"Maomao","year":"2022","journal-title":"Cancer Biol Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/cpt.2843","article-title":"A comparison of FDA and EMA pregnancy and lactation labeling","volume":"113","author":"Kappel","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"ref11","year":"2023"},{"key":"ref12","year":"2023"},{"key":"ref13","year":"2023"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jsps.2017.07.006","article-title":"Comparison of the safety information on drug labels in three developed countries: the USA, UK and Canada","volume":"25","author":"Alshammari","year":"2017","journal-title":"Saudi Pharm J"},{"key":"ref15","year":"2022"},{"key":"ref16","year":"2017"},{"key":"ref17","year":"2022"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/jcpt.12089","article-title":"Differences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom and Japan","volume":"38","author":"Shimazawa","year":"2013","journal-title":"J Clin Pharm Ther"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1002\/jcph.1761","article-title":"The importance of clinical research in pregnant women to inform prescription drug labeling","volume":"60","author":"Dinatale","year":"2020","journal-title":"J Clin Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/cpt.380","article-title":"Medication use in pregnancy and the pregnancy and lactation labeling rule","volume":"100","author":"Sahin","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/art.41550","article-title":"Trends in utilization of urate-lowering therapies following the FDA\u2019S boxed warning to febuxostat in the U.S.","volume":"73","author":"Kim","year":"2021","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e203630","DOI":"10.1001\/jamanetworkopen.2020.3630","article-title":"Association of the US Food and Drug Administration antipsychotic drug boxed warning with medication use and health outcomes in elderly patients with dementia","volume":"3","author":"Rubino","year":"2020","journal-title":"JAMA Netw Open"},{"key":"ref23","volume-title":"Safe and effective medicines for children","year":"2012"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"d7803","DOI":"10.1136\/bmj.d7803","article-title":"Dosing of oral penicillins in children: is big child=half an adult, small child=half a big child, baby=half a small child still the best we can do?","volume":"343","author":"Ahmed","year":"2011","journal-title":"BMJ"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.5414\/CPP49247","article-title":"Getting the dose of vancomycin right in the neonate","volume":"49","author":"Anker","year":"2011","journal-title":"Int J Clin Pharmacol Ther"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1600207\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:20:04Z","timestamp":1763619604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1600207\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":25,"alternative-id":["10.3389\/fmed.2025.1600207"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1600207","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"article-number":"1600207"}}